```mermaid
flowchart TD
VIM["VIM<br/>(Vimentin)"]
%% Autophagy pathway
BECN1["BECN1<br/>(Beclin-1)"]
MAP1LC3B["MAP1LC3B<br/>(LC3B)"]
ATG14["ATG14<br/>(Autophagy Protein)"]
PIK3C3["PIK3C3<br/>(VPS34)"]
UVRAG["UVRAG<br/>(Autophagy Regulator)"]
LAMP1["LAMP1<br/>(Lysosomal Protein)"]
Autophagy["Autophagy<br/>Pathway"]
%% Protein degradation
UPS["Ubiquitin-Proteasome<br/>System"]
HDAC6["HDAC6<br/>(Histone Deacetylase)"]
%% Cellular stress
H2AX["H2AX<br/>(DNA Damage Marker)"]
MAP3K5["MAP3K5<br/>(ASK1 Kinase)"]
%% Disease outcomes
Inflammation["Neuroinflammation"]
Senescence["Cellular<br/>Senescence"]
ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
PD["Parkinson's<br/>Disease"]
MS["Multiple<br/>Sclerosis"]
%% Connections
VIM -->|"regulates"| BECN1
VIM -->|"regulates"| ATG14
VIM -->|"regulates"| Autophagy
VIM -->|"associated with"| MAP1LC3B
VIM -->|"associated with"| PIK3C3
VIM -->|"associated with"| UVRAG
VIM -->|"associated with"| LAMP1
VIM -->|"regulates"| UPS
VIM -->|"associated with"| HDAC6
VIM -->|"regulates"| H2AX
VIM -->|"associated with"| MAP3K5
BECN1 -->|"initiates"| Autophagy
ATG14 -->|"promotes"| Autophagy
MAP1LC3B -->|"mediates"| Autophagy
PIK3C3 -->|"activates"| Autophagy
UVRAG -->|"regulates"| Autophagy
LAMP1 -->|"completes"| Autophagy
VIM -->|"biomarker for"| Inflammation
VIM -->|"biomarker for"| Senescence
VIM -->|"biomarker for"
Vim Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
VIM (Vimentin) encodes a type III intermediate filament protein that is one of the most widely expressed structural proteins in eukaryotic cells. While classically associated with mesenchymal cells, vimentin plays important roles in neuronal function, glial biology, and has been increasingly recognized in neurodegenerative disease pathogenesis. [@goldman2012]
<div class="infobox infobox-gene"> [@raff2010]
<table> [@julien2009]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Vimentin</th></tr> [@vogel2020]
<tr><td><strong>Gene Symbol</strong></td><td>VIM</td></tr>
<tr><td><strong>Full Name</strong></td><td>Vimentin</td></tr>
<tr><td><strong>Chromosome</strong></td><td>10p13</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[7431](https://www.ncbi.nlm.nih.gov/gene/7431)</td></tr>
<tr><td><strong>OMIM</strong></td><td>193060</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000026025</td></tr>
<tr><td><strong>UniProt ID</th><td>[P08670](https://www.uniprot.org/uniprot/P08670)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimer's-disease), [Parkinson's Disease](/diseases/parkinson's-disease), [ALS](/diseases/als), Cataracts</td></tr>
</table>
</div>
The VIM gene spans approximately 9 kb on chromosome 10p13 and consists of 9 exons encoding a 466-amino acid protein with a molecular weight of ~57 kDa. The protein contains:
Vimentin intermediate filaments serve multiple essential cellular functions:
Vimentin is prominently involved in AD pathogenesis through several mechanisms:
Neurofibrillary Tangle Formation
Vimentin is incorporated into abnormal filamentous inclusions in AD brains. The protein undergoes post-translational modifications (hyperphosphorylation, oxidation) that promote aggregation. These vimentin-positive inclusions colocalize with [tau](/proteins/tau) pathology, suggesting a shared mechanism of intermediate filament dysfunction in AD [1].
Glial Activation
Reactive astrocytes expressing vimentin surround amyloid plaques in AD brains. This glial response may be both protective (clearance) and pathological (inflammatory cytokine release). Vimentin-positive astrocytes show increased [GFAP](/entities/gfap) expression, marking the transition to a reactive phenotype [2].
Axonal Transport Defects
Vimentin dysfunction may contribute to axonal transport impairments in AD. The filament network normally supports organelle motility; its disruption could exacerbate [amyloid-beta](/proteins/amyloid-beta)-induced transport deficits.
In PD, vimentin pathology is less prominent than in AD but still relevant:
Glial Activation
Vimentin-positive glia are elevated in the substantia nigra of PD patients. This reflects ongoing neuroinflammation, with vimentin serving as a marker of activated [microglia](/entities/microglia) and astrocytes [3].
Potential Lewy Body Involvement
Some studies report vimentin in Lewy bodies, the characteristic [alpha-synuclein](/mechanisms/alpha-synuclein) inclusions of PD. This suggests vimentin may be recruited into protein aggregates during disease progression.
Intermediate Filament Accumulation
ALS features accumulation of neurofilament proteins; vimentin is often co-deposited in these aggregates. Mutations in [neurofilament light](/biomarkers/neurofilament-light-chain-nfl) chain (NEFL) and other intermediate filament genes cause ALS-like syndromes [4].
Astrocytic Reactivity
Vimentin-expressing astrocytes are prominent in ALS spinal cord. This reactive gliosis precedes motor neuron death and may contribute to disease spread.
Vimentin represents a potential therapeutic target:
| Tissue/Cell Type | Expression Level | Notes |
|------------------|-----------------|-------|
| Fibroblasts | High | Primary expression site |
| Endothelial Cells | Moderate | Vascular cells |
| [Astrocytes](/entities/astrocytes) | Low (baseline), High (reactive) | Disease-associated |
| Schwann Cells | Moderate | Peripheral nerve |
| [Neurons](/entities/neurons) | Very Low | Mainly developmental |
Vimentin interacts with numerous proteins:
Vimentin knockout mice are viable but show:
Vim Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Vim Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following diagram shows the key molecular relationships involving VIM Gene discovered through SciDEX knowledge graph analysis: